Home / Inspections / 1171334

FDA Inspection 1171334 — Seattle Reproductive Medicine, Inc., P.S.

Seattle Reproductive Medicine, Inc., P.S. — FEI 3009672546

The FDA completed an inspection of Seattle Reproductive Medicine, Inc., P.S. on April 7, 2022 in Bellevue, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 7, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bellevue, WA (United States)

Facility

Other inspections at this facility

  • 1293422 (NAI Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1031414 (NAI Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 961640 (NAI Wed Feb 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865541 (NAI Mon Feb 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources